Maurice Ralph Hilleman (August 30, 1919—April 11, 2005)



hi-res

(Photo credit: Courtesy of Merck & Co., Inc.)

Maurice Ralph Hilleman
Patent # 4,017,360 Method for purifying Hepatitis B antigen
Patent # 4,459,286 Coupled H. Influenzae type B vaccine

Maurice Hilleman is recognized as the most prolific vaccine scientist of the 20th century, saving more lives than any other scientist. Most of his long career was at Merck, where he led the development of more than three dozen vaccines, including eight of the fourteen vaccines routinely recommended for children. Among these are vaccines for hepatitis A and B, Haemophilus influenzae type B (Hib), varicella, and the combined vaccine for measles, mumps, and rubella (MMR).

Dr. Hilleman made important contributions outside of vaccine development. He was the first to purify interferon, a discovery that launched new branches of molecular biology and immunology. He co-discovered adenoviruses and characterized the ongoing evolution of flu viruses, which forms the basis for global flu control strategies.

Hilleman was born in Miles City, Montana, and received his Ph.D. from the University of Chicago (1944). He was awarded the National Medal of Science (1988), and a Lifetime Achievement Award from the World Health Organization (1996). His vaccines have virtually eliminated many of the once-common childhood diseases in developed countries.

 


Paul Baran
Emmett W. Chappelle
John E. Franz
Leroy E. Hood
Paul Christian Lauterbur
Peter Mansfield
Robert M. Metcalfe
David Wayne Cushman
Donald Watts Davies
William A. Goddard
Peter Carl Goldmark
Maurice Ralph Hilleman
Godfrey Newbold Hounsfield
John Joseph Lynott
Arthur Nobile
Miguel Angel Ondetti
Otto Wichterle




© 2000-2008 National Inventors Hall of Fame Foundation, Inc.
return to hall of fame home page